Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel interacting protein 4 (KCNIP4) is a small calcium-binding protein that functions as an auxiliary subunit for voltage-gated A-type potassium (Kv4) channels, especially prevalent in brain and heart tissues. KCNIP4 contains EF-hand domains characteristic of calcium sensor proteins, and directly regulates Kv4 channel kinetics (activation, inactivation, and recovery) and trafficking to the cell membrane in response to intracellular calcium levels. These interactions have significant effects on neuronal excitability and signal integration. KCNIP4 also binds to presenilin proteins—implicated in neurodegenerative diseases—and is expressed in select neuronal networks. Genetic variants in KCNIP4 have been linked to psychiatric disease susceptibility, antidepressant side effects, and asthma risk. No drugs are known to target KCNIP4 directly, but its regulatory influence over Kv4 channels positions it as a potential candidate for modulating excitability disorders and as a biomarker for certain neuropsychiatric and airway disorders.
Auxiliary regulation of Kv4 channels—modulates channel gating, inactivation, and recovery; stabilization of channel complexes at plasma membrane through direct binding; in isoform-specific cases, alters current kinetics and localization; no direct drugs, so not drug action mechanism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel interacting protein 4 (KCNIP4).